Among health care workers who have occupational exposures tothe human immunodeficiency virus (HIV), a recent casecontrolstudy indicates that treatment with zidovudine after exposuredecreases the odds of HIV infection by 79 percent.1 Althoughthis observation has not been confirmed in a randomized, controlledtrial, antiretroviral treatment is now the standard of carein the event of a parenteral occupational exposure to HIV.2,3,4The probability of HIV infection due to puncture by a contaminatedneedle is similar to that estimated for a single episode ofunprotected receptive anal or vaginal intercourse with an infectedpartner or for a single . . . [Full Text of this Article]
Risks Associated with Sexual and Injection-Drug Exposures
The Efficacy and Safety of Postexposure Treatment
Risks Associated with Postexposure Treatment
Recommendations for Treatment
Toward a Public Health Policy
Conclusions
Address reprint requests to Dr. Katz at the AIDS Office, 25 Van Ness Ave., Suite 500, San Francisco, CA 94102-6033.
References
Related Letters:
Postexposure Treatment of HIV
Li R. W., Wong J. B., Pinkerton S. D., Holtgrave D. R., Bloom F. R., Katz M. H., Gerberding J. L.
Extract |
Full Text
N Engl J Med 1997;
337:499-501, Aug 14, 1997.
Correspondence
This article has been cited by other articles:
Pinkerton, S. D., Benotsch, E. G., Mikytuck, J.
(2007). When Do Simpler Sexual Behavior Data Collection Techniques Suffice?: An Analysis of Consequent Uncertainty in HIV Acquisition Risk Estimates. Eval Rev
31: 401-412
[Abstract]
Sonder, G. J B, Regez, R. M, Brinkman, K., Prins, J. M, Mulder, J.-W., Spaargaren, J., Coutinho, R. A, van den Hoek, A.
(2005). Prophylaxis and follow-up after possible exposure to HIV, hepatitis B virus, and hepatitis C virus outside hospital: evaluation of policy 2000-3. BMJ
330: 825-829
[Abstract][Full Text]
Theobald, S., Taegtmeyer, M.
(2005). Gender, health and development (II): gender equity and access to antiretroviral drugs. Progress in Development Studies
5: 144-148
Pinkerton, S. D., Martin, J. N., Roland, M. E., Katz, M. H., Coates, T. J., Kahn, J. O.
(2004). Cost-effectiveness of Postexposure Prophylaxis After Sexual or Injection-Drug Exposure to Human Immunodeficiency Virus. Arch Intern Med
164: 46-54
[Abstract][Full Text]
Havens, P. L., Committee on Pediatric AIDS,
(2003). Postexposure Prophylaxis in Children and Adolescents for Nonoccupational Exposure to Human Immunodeficiency Virus. Pediatrics
111: 1475-1489
[Abstract][Full Text]
Merchant, R. C., Keshavarz, R.
(2001). Human Immunodeficiency Virus Postexposure Prophylaxis for Adolescents and Children. Pediatrics
108
: e38-e38
[Abstract][Full Text]
Babl, F. E., Cooper, E. R., Kastner, B., Kharasch, S.
(2001). Prophylaxis Against Possible Human Immunodeficiency Virus Exposure After Nonoccupational Needlestick Injuries or Sexual Assaults in Children and Adolescents. Arch Pediatr Adolesc Med
155: 680-682
[Abstract][Full Text]
Radecki, S., Abbott, A., Eloi, L.
(2000). Occupational Human Immunodeficiency Virus Exposure Among Residents and Medical Students: An Analysis of 5-Year Follow-up Data. Arch Intern Med
160: 3107-3111
[Abstract][Full Text]
Otten, R. A., Smith, D. K., Adams, D. R., Pullium, J. K., Jackson, E., Kim, C. N., Jaffe, H., Janssen, R., Butera, S., Folks, T. M.
(2000). Efficacy of Postexposure Prophylaxis after Intravaginal Exposure of Pig-Tailed Macaques to a Human-Derived Retrovirus (Human Immunodeficiency Virus Type 2). J. Virol.
74: 9771-9775
[Abstract][Full Text]
Donovan, B.
(2000). The repertoire of human efforts to avoid sexually transmissible diseases: past and present. Part 2: Strategies used during or after sex. Sex. Transm. Infect.
76: 88-93
[Abstract][Full Text]
Atabaki, S., Paradise, J. E.
(1999). The Medical Evaluation of the Sexually Abused Child: Lessons From a Decade of Research. Pediatrics
104: 178-178
[Full Text]
Henderson, D. K.
(1999). Postexposure Chemoprophylaxis for Occupational Exposures to the Human Immunodeficiency Virus. JAMA
281: 931-936
[Full Text]
Lurie, P., Miller, S., Hecht, F., Chesney, M., Lo, B.
(1998). Postexposure Prophylaxis After Nonoccupational HIV Exposure: Clinical, Ethical, and Policy Considerations. JAMA
280: 1769-1773
[Abstract][Full Text]
De Groot, A. S., Leibel, S. R., Zierler, S.
(1998). A Standard of HIV Care for Incarcerated Women: Northeastern United States' Experiences. JOURNAL OF CORRECTIONAL HEALTH CARE
5: 139-177
[Abstract]
Wainberg, M. A., Friedland, G.
(1998). Public Health Implications of Antiretroviral Therapy and HIV Drug Resistance. JAMA
279: 1977-1983
[Abstract][Full Text]
(1998). It's Not Over Till It's Over. AIDS Clin Care
1998: 2-2
[Full Text]
(1998). Post-Sexual Exposure Prophylaxis: A Roundtable Discussion. AIDS Clin Care
1998: 1-1
[Full Text]
Cardo, D. M., Culver, D. H., Ciesielski, C. A., Srivastava, P. U., Marcus, R., Abiteboul, D., Heptonstall, J., Ippolito, G., Lot, F., McKibben, P. S., Bell, D. M., The Centers for Disease Control and Prevention Nee,
(1997). A Case-Control Study of HIV Seroconversion in Health Care Workers after Percutaneous Exposure. NEJM
337: 1485-1490
[Abstract][Full Text]
Dilley, J. W., Woods, W. J., McFarland, W.
(1997). Are Advances in Treatment Changing Views about High-Risk Sex?. NEJM
337: 501-502
[Full Text]
Li, R. W., Wong, J. B., Pinkerton, S. D., Holtgrave, D. R., Bloom, F. R., Katz, M. H., Gerberding, J. L.
(1997). Postexposure Treatment of HIV. NEJM
337: 499-501
[Full Text]
(1997). Postexposure Prophylaxis for HIV. AIDS Clin Care
1997: 1-1
[Full Text]
Royce, R. A., Sena, A., Cates, W., Cohen, M. S.
(1997). Sexual Transmission of HIV. NEJM
336: 1072-1078
[Full Text]